1
|
Warnier H, Barrea C, Bethlen S, Schrouff I, Harvengt J. Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review. Orphanet J Rare Dis 2022; 17:174. [PMID: 35461249 PMCID: PMC9034487 DOI: 10.1186/s13023-022-02323-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Accepted: 04/09/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Stuve-Wiedemann syndrome (SWS) is a rare and severe genetic disease characterized by skeletal anomalies and dysautonomic disturbances requiring appropriate care. Peer support is mandatory to fill the lack of clinical recommendations in such rare diseases. We report a new case and provide the first systematic review of all previous published cases. OBJECTIVE To better describe the timeline of SWS and to improve paediatric management. DATA SOURCES SWS English publications available on Pubmed until 31/03/2021. STUDY SELECTION Case description combining typical osteo-articular and dysautonomic involvement (with 2 items by categories required for children < 2 years and 3 items > 2 years). DATA EXTRACTION Demographic, clinical, genetics and outcome data. RESULTS In our cohort of 69 patients, the median age at report was 32 months. Only 46% presented antenatal signs. Mortality rate is higher during the first 2 years (42% < 2 years; 10% > 2 years) mainly due to respiratory failure, pulmonary arterial hypertension appearing to be a poor prognosis factor (mortality rate 63%). After 2 years, orthopaedic symptoms significantly increase including joint mobility restriction (81%), spinal deformations (77%) and fractures (61%). CONCLUSIONS Natural history of SWS is marked by a high mortality rate before 2 years due to dysautonomic disturbances. A specialized multidisciplinary approach is needed to address these early mortality risks and then adapt to the specific, mainly orthopaedic, needs of patients after 2 years of age. Further research is required to provide clinical guidelines and improve pre-natal counselling.
Collapse
Affiliation(s)
| | - Christophe Barrea
- Department of Paediatrics, Neuropeadiatrics, CHU of Liège, Liège, Belgium
| | - Sarah Bethlen
- Department of Physical Medicine, CHU of Liège, Liège, Belgium
| | | | - Julie Harvengt
- Department of Human Genetics, CHU of Liège, Avenue de l'Hôpital 1, Sart-Tilman, 4000, Liège, Belgium.
| |
Collapse
|
2
|
Alallah J, Alamoudi LO, Makki RM, Shawli A, AlHarbi AT. Stüve-Wiedemann syndrome with a novel mutation in a Saudi infant. Int J Pediatr Adolesc Med 2021; 9:143-146. [PMID: 35663789 PMCID: PMC9152555 DOI: 10.1016/j.ijpam.2021.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 09/17/2021] [Accepted: 10/06/2021] [Indexed: 12/04/2022]
Abstract
A full-term male infant born from consanguineous Saudi parents, with one other live child, is suspected to have skeletal dysplasia on a fetal anomaly scan. Clinical findings at birth included short stature, bowed long bone affecting the lower limbs more than the upper limbs, severe joint contractures with restricted movement, failure to thrive, hypertonia, and camptodactyly of the index fingers. During infancy, the baby is noted to have sucking and swallowing difficulties necessitated nasogastric tube feeding, and recurrent respiratory distress episodes with frequent admissions due to respiratory failure required intensive care admission and mechanical ventilation. The skeletal survey demonstrated dysplasia of long bones and spine. To investigate a suspect genetic syndrome, a whole-exome sequencing test was performed, which identified a novel homozygous mutation in the LIFR gene.
Collapse
Affiliation(s)
- Jubara Alallah
- Neonatology Section, Paediatric Department, King Abdulaziz Medical City-WR, Ministry Of National Guard, Saudi Arabia
- King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia
- King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
- Corresponding author. King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Neonatology Section, Pediatric Department, king Abdulaziz Medical City, National Guard health Affair, Jeddah, Kingdom of Saudi Arabia. P.O.Box 9515, Jeddah, 2123, Saudi Arabia.
| | - Loujen Omar Alamoudi
- King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia
- King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Reham Mohmmed Makki
- King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia
- King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Aiman Shawli
- King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia
- King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
- Departments of Clinical Genetics, King Abdulaziz Medical City, Jeddah, Saudi Arabia
| | | |
Collapse
|
3
|
Siccha SM, Cueto AM, Parrón-Pajares M, González-Morán G, Pacio-Miguez M, Del Pozo Á, Solís M, Rodriguez-Jimenez C, Caino S, Fano V, Heath KE, García-Miñaúr S, Palomares-Bralo M, Santos-Simarro F. Delineation of the clinical and radiological features of Stuve-Wiedemann syndrome childhood survivors, four new cases and review of the literature. Am J Med Genet A 2020; 185:856-865. [PMID: 33305909 DOI: 10.1002/ajmg.a.62010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Revised: 09/08/2020] [Accepted: 11/14/2020] [Indexed: 11/07/2022]
Abstract
Stuve-Wiedemann syndrome (SWS; MIM 601559) is a rare autosomal recessive disease caused by mutations in the leukemia inhibitor factor receptor gene (LIFR). Common clinical and radiological findings are often observed, and high neonatal mortality occurs due to respiratory distress and hyperthermic episodes. Despite initially considered as a lethal disorder during the newborn period, in recent years, several SWS childhood survivors have been reported. We report a detailed clinical and radiological characterization of four unrelated childhood SWS molecularly confirmed patients and review 22 previously reported childhood surviving cases. We contribute to the definition of the childhood survival phenotype of SWS, emphasizing the evolving phenotype, characterized by skeletal abnormalities with typical radiological findings, distinctive dysmorphic features, and dysautonomia. Based on the typical features and clinical course, early diagnosis is possible and crucial to plan appropriate management and prevent potential complications. Genetic confirmation is advisable in order to improve genetic counseling to the patients and their families.
Collapse
Affiliation(s)
- Sofía M Siccha
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Department of Pediatrics, Hospital Universitario la Paz, Madrid, Spain
| | - Anna María Cueto
- Department of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.,Medical Genetics Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.,European Reference Network, ERN CRANIO, Barcelona, Spain
| | - Manuel Parrón-Pajares
- Department of Radiology, Hospital Universitario La Paz, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain
| | - Gaspar González-Morán
- Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Department of Orthopaedic Surgery and Traumatology, Hospital Universitario la Paz, Madrid, Spain
| | - Marta Pacio-Miguez
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain
| | - Ángela Del Pozo
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Mario Solís
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Carmen Rodriguez-Jimenez
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain
| | - Silvia Caino
- Growth and Developmental Department Hospital de Pediatría Garrahan, Buenos Aires, Argentina
| | - Virginia Fano
- Growth and Developmental Department Hospital de Pediatría Garrahan, Buenos Aires, Argentina
| | - Karen E Heath
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Sixto García-Miñaúr
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - María Palomares-Bralo
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Fernando Santos-Simarro
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| |
Collapse
|
4
|
Ramdeny PS, Powell C, Chakraborty M, Hartley L. Rhabdomyolysis in Stuve-Wiedemann syndrome. BMJ Case Rep 2018; 2018:bcr-2017-222863. [DOI: 10.1136/bcr-2017-222863] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
|
5
|
Developments in the Orthopaedic Management of Children With Stüve-Wiedemann Syndrome: Use of the Fassier-Duval Telescopic Rod to Maintain Correction of Deformity. J Pediatr Orthop 2017; 37:e459-e463. [PMID: 26650577 DOI: 10.1097/bpo.0000000000000711] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND Stüve-Wiedemann syndrome is a rare inherited condition, which is frequently fatal in infancy. Those patients who survive into childhood demonstrate a complex progressive deformity of the long bones, with high rates of recurrence after initial successful correction. Because of the rarity of the condition there is, at present, limited evidence on the most appropriate treatment. METHODS We describe our experience in the management of 4 patients, who underwent correction of deformity and fixation with Fassier-Duval telescopic rods. RESULTS In this series we have seen good correction of deformity and maintenance of alignment, with improvement in the walking ability of children treated with this technique. CONCLUSION Fassier-Duval rodding has a role in the prevention of recurrence of deformity and should be considered as a means to reduce the number of operative procedures required. LEVEL OF EVIDENCE Level IV-therapeutic.
Collapse
|
6
|
Abstract
PURPOSE Stuve-Wiedemann syndrome is a rare condition consisting of bone dysplasia, hypotony, and dysautonomia with ocular and neuropathic features. We present the ocular findings and visual outcome in 4 patients (2 siblings, 1 related cousin, and 1 unrelated patient) with this syndrome. METHODS A retrospective case series review. Clinical notes of 4 patients with Stuve-Wiedemann syndrome were reviewed for findings of systemic features, ocular examination, visual acuity, and ocular procedures. RESULTS The median age at presentation was 16 months (range, 14-72 months). All 4 cases consisted of bilateral plaque-like corneal scarring with reduced corneal sensation. Treatment comprised topical lubrication, punctal plugs, lateral tarsorrhaphies, surgical optical iridectomies when required, and aggressive visual rehabilitation with frequent refraction and occlusion therapy if necessary. Mean best-corrected visual acuity (BCVA) in the eye with best vision was 0.86 logarithm of the minimum angle of resolution (logMAR) (range, 0.72-1.1 logMAR) at presentation and 0.43 logMAR (range, 0.25-0.56 logMAR) at the last follow-up. The BCVA in the eye with worst vision was 0.98 logMAR (range, 0.72-1.3 logMAR) at presentation and 0.68 logMAR (range, 0.47-1.0 logMAR) at the last follow-up. The median follow-up was 3.2 years (range, 1.1-5.8 years). CONCLUSIONS All of our patients showed improved BCVA with the treatment regimen prescribed. Given these children's debilitating orthopedic problems, visual function is important and has hitherto been reported as being poor.
Collapse
|
7
|
Abstract
Stüve-Wiedemann syndrome (SWS) is a severe congenital skeletal dysplasia associated with life threatening dysautonomic manifestations. Newborns affected with this condition exhibit distinctive shortening and bowing of the long bones with reduced bone volume. The majority of affected newborns die early due to neuromuscular complications namely hyperthermia, apnea, and swallowing difficulties. In this review, we provide an overall picture on the clinical, including long-term management, molecular and cellular aspects of SWS and discuss briefly other related bent bone dysplasias.
Collapse
Affiliation(s)
- N A Akawi
- Department of Pathology Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
| | | | | |
Collapse
|
8
|
Differential secretion of the mutated protein is a major component affecting phenotypic severity in CRLF1-associated disorders. Eur J Hum Genet 2011; 19:525-33. [PMID: 21326283 DOI: 10.1038/ejhg.2010.253] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Crisponi syndrome (CS) and cold-induced sweating syndrome type 1 (CISS1) are disorders caused by mutations in CRLF1. The two syndromes share clinical characteristics, such as dysmorphic features, muscle contractions, scoliosis and cold-induced sweating, with CS patients showing a severe clinical course in infancy involving hyperthermia, associated with death in most cases in the first years of life. To evaluate a potential genotype/phenotype correlation and whether CS and CISS1 represent two allelic diseases or manifestations at different ages of the same disorder, we carried out a detailed clinical analysis of 19 patients carrying mutations in CRLF1. We studied the functional significance of the mutations found in CRLF1, providing evidence that phenotypic severity of the two disorders mainly depends on altered kinetics of secretion of the mutated CRLF1 protein. On the basis of these findings, we believe that the two syndromes, CS and CISS1, represent manifestations of the same disorder, with different degrees of severity. We suggest renaming the two genetic entities CS and CISS1 with the broader term of Sohar-Crisponi syndrome.
Collapse
|
9
|
Jung C, Dagoneau N, Baujat G, Le Merrer M, David A, Di Rocco M, Hamel B, Mégarbané A, Superti-Furga A, Unger S, Munnich A, Cormier-Daire V. Stüve-Wiedemann syndrome: long-term follow-up and genetic heterogeneity. Clin Genet 2010; 77:266-72. [PMID: 20447141 DOI: 10.1111/j.1399-0004.2009.01314.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Stüve-Wiedemann syndrome (SWS, OMIM 601559) is a severe autosomal recessive condition caused by mutations in the leukemia inhibitory receptor (LIFR) gene. The main characteristic features are bowing of the long bones, neonatal respiratory distress, swallowing/sucking difficulties and dysautonomia symptoms including temperature instability often leading to death in the first years of life. We report here four patients with SWS who have survived beyond 36 months of age with no LIFR mutation. These patients have been compared with six unreported SWS survivors carrying null LIFR mutations. We provide evidence of clinical homogeneity of the syndrome in spite of the genetic heterogeneity.
Collapse
Affiliation(s)
- C Jung
- Department of Genetics, Université Paris Descartes, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Hassan A, Whately C, Letts M. The orthopaedic manifestations and management of children with Stüve-Wiedemann syndrome. ACTA ACUST UNITED AC 2010; 92:880-4. [DOI: 10.1302/0301-620x.92b6.23486] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Stüve-Wiedemann syndrome is an autosomal-recessive disorder characterised by bowing of the long bones, progressive scoliosis, episodic hyperthermia and respiratory distress, usually resulting in death in infancy. We reviewed five children with the condition who had been followed since birth and who survived into childhood with a mean age at operation of 7.8 years (5 to 14). There was marked functional impairment with dysplasia of the long bones and scoliosis. Treatment of the triplanar deformities of the femora involved the use of the Ilizarov technique with the Taylor Spatial Frame. Walking was preserved and improved in three children along with considerable enhancement of the appearance. Early insertion of a growing rod to control the progressive juvenile scoliosis was beneficial. The use of the Taylor Spatial Frame is strongly recommended to address the major complex deformities of the lower limbs which are encountered in this condition and to prevent their progression.
Collapse
Affiliation(s)
- A. Hassan
- Division of Orthopaedic Surgery Sheikh Khalifa Medical City, PO 5190 Abu Dhabi, United Arab Emirates
| | - C. Whately
- Division of Orthopaedic Surgery Welcare Hospital, PO 215565 Dubai, United Arab Emirates
| | - M. Letts
- 66 216 Botanica, Ottawa, Ontario L1Y 4P9, Canada
| |
Collapse
|
11
|
Abnormal oral-pharyngeal swallowing as cause of morbidity and early death in Stüve-Wiedemann syndrome. Eur J Med Genet 2009; 52:242-6. [PMID: 19371797 DOI: 10.1016/j.ejmg.2009.04.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2008] [Accepted: 04/02/2009] [Indexed: 11/21/2022]
Abstract
Stüve-Wiedemann syndrome (SWS) is an autosomal recessive bone dysplasia (OMIM #601559) characterized by bowing of long bones, camptodactyly, respiratory insufficiency, hyperthermic episodes, and neonatal death from hyperthermia or apnea. We describe two female siblings with SWS born from consanguineous Gypsy parents. For a further delineation of SWS, we report hypothyroidism and ectopic thyroid as part of its phenotypic spectrum. Molecular study in the leukemia inhibitory factor receptor (LIFR) gene (OMIM *151 443) demonstrated the presence of a mutation. We observed that in one of our patients, oropharyngeal disruption in the swallowing process caused repetitive aspiration pneumonias, life-threatening events, and finally death. We emphasize that these features represent dysautonomic manifestations of SWS, and are probably related to pharyngoesophageal dyskinesia due to abnormal autonomic control of the anterior rami of cervical roots C1-C5.
Collapse
|
12
|
Bonthuis D, Morava E, Booij LHDJ, Driessen JJ. Stuve Wiedemann syndrome and related syndromes: case report and possible anesthetic complications. Paediatr Anaesth 2009; 19:212-7. [PMID: 19207241 DOI: 10.1111/j.1460-9592.2008.02891.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Stuve Wiedemann syndrome (SWS) is an autosomal recessively inherited syndrome which is characterized by bowing of the long bones, camptodactyly, facial dysmorphism, hypotonia, feeding and swallowing difficulties, and respiratory distress. In most cases episodes of unexplained hyperthermia are present. Patients with SWS can develop hyperthermia in conjunction with anesthesia and surgery, and a relationship has been suggested between the syndrome and malignant hyperthermia. We describe a 3-year-old child diagnosed with SWS to whom we administered general anesthesia during the removal of a corneal ulcer and dilatation of the lacrimal duct. Our patient had received, uncomplicated, inhalational anesthesia five times previously for different operations. There were no anesthesia-related complications in the present or previous perioperative periods. On one occasion the patient developed mild postoperative hyperthermia. We believe that this hyperthermia is different from the specific disorder of malignant hyperthermia and that sevoflurane can be safely used in patients with SWS. We also describe symptomatically related syndromes and their theoretical risks for anesthesia.
Collapse
Affiliation(s)
- Dominique Bonthuis
- Department of Anesthesiology, Pain and Palliative Care, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands
| | | | | | | |
Collapse
|
13
|
Al Kaissi A, Rumpler M, Csepan R, Grill F, Klaushofer K. Congenital contractures and distinctive phenotypic features consistent with Stuve-Wiedmann syndrome in a male infant. CASES JOURNAL 2008; 1:121. [PMID: 18718019 PMCID: PMC2533000 DOI: 10.1186/1757-1626-1-121] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/17/2008] [Accepted: 08/21/2008] [Indexed: 12/03/2022]
Abstract
Introduction Expressionless face associated with multiple contractures has been encountered in an infant. There is a wide range of misconception regarding the categorization of children with multiple contractures among different pediatric disciplines. The fundamental element in categorizing children with multiple contractures is "the etiological understanding". In the absence of concomitant neuromuscular disease, however, the search for other reasons is mandatory. Our present paper signifies the necessity of proper interpretations of unusual clinical and radiographic features. Case presentation We describe a 3-months-old-infant presented with the phenotypic and the radiographic features consistent with the diagnosis of Stüve-Wiedemann syndrome. We report what might be the first clinical report of Stüve-Wiedemann syndrome from a consanguineous family in Austria. Conclusion Congenital limitations of the hips in a newborn infant raise the possibility of " Congenital Hip Dislocation". As congenital hip dislocation is a dysplastic process. Here further knowledge by the pediatrician and the orthopaedic surgeon is needed. Our present patient appears to constitute a distinct pathological entity consistent with Stüve-Wiedemann syndrome (SWS). Superti-Furga et al, and Cormier-Daire et al, also suggest that Stüve-Wiedemann syndrome and Schwartz-Jampel syndrome type 2 are allelic conditions. We wish to stress that, given the rarity of syndromic malformation complex, our impression is that it is more common than it is reported.
Collapse
Affiliation(s)
- Ali Al Kaissi
- Ludwig Boltzmann Institute of Osteology, at the Hanusch Hospital of WGKK and, AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria.
| | | | | | | | | |
Collapse
|
14
|
Gaspar IM, Saldanha T, Cabral P, Vilhena MM, Tuna M, Costa C, Dagoneau N, Daire VC, Hennekam RCM. Long-term follow-up in Stuve-Wiedemann syndrome: a clinical report. Am J Med Genet A 2008; 146A:1748-53. [PMID: 18546280 DOI: 10.1002/ajmg.a.32325] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Stuve-Wiedemann syndrome (SWS) is an autosomal recessively inherited disorder that is usually associated with high mortality in the neonatal period. Eleven cases have been published with prolonged survival, the oldest being 16 years. This phenotype is characterized by progressive skeletal anomalies including short stature, severe spinal deformities, bowing of the long bones, contractures and spontaneous fractures, and by neurological features that resemble dysautonomia. Here we report on the natural history of a Portuguese girl from birth till 12 years. The diagnosis was molecularly confirmed by the detection of a homozygous 4 bp deletion (167_170 del TAAC) in exon 3 of LIFR. We compare the findings in this patient to other patients with prolonged survival from the literature.
Collapse
|
15
|
Langer R, Al-Gazali L, Raupp P, Varady E. Radiological manifestations of the skeleton, lungs and brain in Stueve-Wiedemann syndrome. AUSTRALASIAN RADIOLOGY 2007; 51:203-10. [PMID: 17504309 DOI: 10.1111/j.1440-1673.2007.01714.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A total of 25 patients with the rare skeletal dysplasia Stueve-Wiedemann syndrome (SWS) have been evaluated during the last 11 years. Of all patients with clinical suspicion of SWS, skeletal and chest radiographs were obtained for classification of the underlying skeletal dysplasia. In one case, CT was carried out for the first time for further investigation of the midface hypoplasia. Typical conventional radiological findings and CT features were analysed and compared with published data. Early diagnosis of SWS was made by correlating radiological and clinical findings. Follow-up radiological examinations of the skeleton and of the chest were carried out in six children surviving infancy for evaluation of progression. Clinically, they suffered from progressive orthopaedic problems, recurrent aspiration pneumonia and recurrent episodes of hyperthermia, as well as cutaneous infections. Radiologically progressive bowing of the long tubular bones and progressive metaphyseal decalcification were present on follow-up skeletal radiographs. Skeletal abnormalities in SWS are so characteristic that an early post-partum diagnosis can be made by correlation of typical clinical and radiological findings. Few cases survive infancy. First, these patients face progressive orthopaedic problems and respiratory infections.
Collapse
Affiliation(s)
- R Langer
- Department of Radiology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
| | | | | | | |
Collapse
|
16
|
Dagoneau N, Scheffer D, Huber C, Al-Gazali LI, Di Rocco M, Godard A, Martinovic J, Raas-Rothschild A, Sigaudy S, Unger S, Nicole S, Fontaine B, Taupin JL, Moreau JF, Superti-Furga A, Le Merrer M, Bonaventure J, Munnich A, Legeai-Mallet L, Cormier-Daire V. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 2004; 74:298-305. [PMID: 14740318 PMCID: PMC1181927 DOI: 10.1086/381715] [Citation(s) in RCA: 128] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2003] [Accepted: 11/11/2003] [Indexed: 11/03/2022] Open
Abstract
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality. Clinical overlap with Schwartz-Jampel type 2 syndrome (SJS2) has suggested that SWS and SJS2 could be allelic disorders. Through studying a series of 19 families with SWS/SJS2, we have mapped the disease gene to chromosome 5p13.1 at locus D5S418 (Zmax=10.66 at theta =0) and have identified null mutations in the leukemia inhibitory factor receptor (LIFR or gp190 chain) gene. A total of 14 distinct mutations were identified in the 19 families. An identical frameshift insertion (653_654insT) was identified in families from the United Arab Emirates, suggesting a founder effect in that region. It is interesting that 12/14 mutations predicted premature termination of translation. Functional studies indicated that these mutations alter the stability of LIFR messenger RNA transcripts, resulting in the absence of the LIFR protein and in the impairment of the JAK/STAT3 signaling pathway in patient cells. We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.
Collapse
Affiliation(s)
- Nathalie Dagoneau
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Deborah Scheffer
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Céline Huber
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Lihadh I. Al-Gazali
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Maja Di Rocco
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Anne Godard
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jelena Martinovic
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Annick Raas-Rothschild
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sabine Sigaudy
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sheila Unger
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sophie Nicole
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Bertrand Fontaine
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jean-Luc Taupin
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jean-François Moreau
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Andrea Superti-Furga
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Martine Le Merrer
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jacky Bonaventure
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Arnold Munnich
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Laurence Legeai-Mallet
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Valérie Cormier-Daire
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| |
Collapse
|
17
|
Abstract
Crisponi syndrome was described in the original paper in 17 patients form 12 families [Crisponi, 1996: Am J Med Genet 62:365-371]. It is characterised by episodes of muscle contraction in response to external stimuli and intermittent hypethermia with neonatal onset. The disease is often lethal in the first infancy. We describe a patient with the same unusual phenotype.
Collapse
Affiliation(s)
- P Accorsi
- Divisione di Neuropsichiatria Infantile, A.O. Spedali Civili di Brescia, Piazzale Spedali Civili, 25123 Brescia, Italy.
| | | | | |
Collapse
|
18
|
Raas-Rothschild A, Ergaz-Schaltiel Z, Bar-Ziv J, Rein AJJT. Cardiovascular abnormalities associated with the Stuve-Wiedemann syndrome. Am J Med Genet A 2003; 121A:156-8. [PMID: 12910496 DOI: 10.1002/ajmg.a.20066] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The Stuve-Wiedemann syndrome (SWS) is a congenital bone dysplasia characterized by camptodactyly with ulnar deviation and congenital bowing of the long bones. Affected patients present with respiratory difficulties in the neonatal period or later and recurrent episodes of hyperthermia. The typical radiological findings are bowing of the long bones of the lower limbs, wide metaphyses with decreased density, and abnormal trabecular pattern. Generally, respiratory insufficiency and hyperthermia are reported to be the cause of death. We report on two sibs with SWS, who died from severe pulmonary hypertension with pulmonary artery wall abnormality. We suggest a common pathophysiological process, which could explain the cardiovascular findings that we observed immediately after birth in the two affected sibs. We hypothesize that the severe pulmonary hypertension due to the arterial wall abnormality could explain the neonatal death of these two children.
Collapse
|
19
|
Di Rocco M, Dodero P. Concerning "Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol". Am J Med Genet A 2003; 118A:199. [PMID: 12698963 DOI: 10.1002/ajmg.a.10879] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
20
|
Al-Gazali LI, Ravenscroft A, Feng A, Shubbar A, Al-Saggaf A, Haas D. Stüve-Wiedemann syndrome in children surviving infancy: clinical and radiological features. Clin Dysmorphol 2003; 12:1-8. [PMID: 12514358 DOI: 10.1097/00019605-200301000-00001] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
We report three children from two inbred Arab families with Stüve-Wiedemann syndrome who have survived the first year of life (ages are 6 years, 2.8 years and 2 years). All exhibited a characteristic phenotype resembling that described by Chen et al.[(2001). Am J Med Genet 101:240-245]. In all three children the skeletal abnormalities progressed to severe bowing of the long bones with prominent joints and severe spinal deformity. Neurological symptoms were present in all of them. These included temperature instability with excessive sweating, reduced pain sensation with repeated injury to the tongue and limbs, absent corneal reflexes and a smooth tongue. Mentality was normal in all of them. Radiological changes included under tubulation of the diaphyses, rarefaction and striation of metaphyses, destruction of the femoral heads and spinal deformity. We confirm that survival in this syndrome is possible and that the prognosis improves after the first year of life. This should be taken into consideration when counselling parents of affected children. This report further supports the existence of a characteristic phenotype in Stüve-Wiedemann syndrome survivors which include, in addition to the skeletal abnormalities and distinctive radiological features, neurological symptoms reminiscent of dysautonomia.
Collapse
Affiliation(s)
- L I Al-Gazali
- Paediatrics Department, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates.
| | | | | | | | | | | |
Collapse
|
21
|
Farra C, Piquet C, Guillaume M, D'Ercole C, Philip N. Congenital bowing of long bones: prenatal ultrasound findings and diagnostic dilemmas. Fetal Diagn Ther 2002; 17:236-9. [PMID: 12065952 DOI: 10.1159/000059376] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
OBJECTIVE Bowing of the long bones can be easily detected on antenatal ultrasound screening, but it is a nonspecific sign that can be associated with a variety of conditions, each denoting a different prognosis. Among these conditions, three well-differentiated bone dysplasias share bowed long bones as a main clinical manifestation. Campomelic dysplasia and Stüve-Wiedemann syndrome are characterized by a poor prognosis. Conversely, the overall prognosis of children affected with kyphomelic dysplasia is good, the intelligence and motor development are normal and the radiological abnormalities tend to improve and regress with age. CASE REPORT We report a case of prenatal detection of short and bowed femora at the 22nd week of gestation. Careful US examination as well as in utero X-ray of the skeleton allowed the exclusion of campomelic dysplasia. In the absence of an unambiguous diagnosis, the pregnancy was continued. At birth, the child presented with clinical and radiological features consistent with a diagnosis of kyphomelic dysplasia. CONCLUSION This case illustrates the difficulties in making an accurate diagnosis and consequently giving a prognosis when isolated femoral bowing is found on fetal ultrasound examination.
Collapse
Affiliation(s)
- Chantal Farra
- Centre de diagnostic prénatal, Département de Génétique médicale, Hôpital d'Enfants de la Timone, Assistance publique des Hôpitaux de Marseille, F-13385 Marseille Cedex 5, France
| | | | | | | | | |
Collapse
|
22
|
Guala A, Biroli E, Bassini P, Botta G, Licata D, Di Cara G, Franceschini D, Franceschini P. Prenatal diagnosis of kyphomelic dysplasia. Prenat Diagn 2002. [PMID: 11787041 DOI: 10.1002/pd.193] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Kyphomelic dysplasia (KD) is a rare autosomal recessive entity characterized by disproportionate dwarfism with shortening and bowing of the limbs, narrow chest, 11 ribs and metaphyseal flaring. Mental development is generally normal. We report the in utero ultrasound appearances and post-mortem radiographic findings of a 22-week-old male fetus suggestive of KD. A review of 19 previously reported patients with KD is also presented.
Collapse
Affiliation(s)
- A Guala
- Ambulatori di Genetica, Borgosesia e Vercelli, ASL 11, Italy
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Chen E, Cotter PD, Cohen RA, Lachman RS. Characterization of a long-term survivor with Stüve-Wiedemann syndrome and mosaicism of a supernumerary marker chromosome. AMERICAN JOURNAL OF MEDICAL GENETICS 2001; 101:240-5. [PMID: 11424139 DOI: 10.1002/ajmg.1382] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Stüve-Wiedemann syndrome (SWS) is typically lethal in the neonatal period; only two patients have been reported with a longer survival. We report a new patient with SWS, who at 9 years of age is one of the longest survivors with this disorder. In addition to the characteristic features of SWS, she has a number of unique clinical signs, including lack of corneal and patellar reflexes, a smooth tongue with no fungiform papillae, chronic gingival abscesses, mottled, poor dentition, blotchy pigmentation of the skin, unusual infections, multiple fractures, and progressive scoliosis. Cytogenetic analysis identified mosaicism for a supernumerary marker chromosome (SMC), seen in the majority of amniocytes, blood, and skin fibroblasts. The SMC was shown to be derived from chromosome 5 and contains euchromatin. The significance of the SMC to the etiology of SWS is unknown. This patient further demonstrates that SWS is not universally lethal.
Collapse
Affiliation(s)
- E Chen
- Division of Medical Genetics, Children's Hospital Oakland, Oakland, California 94609, USA.
| | | | | | | |
Collapse
|
24
|
Superti-Furga A, Tenconi R, Clementi M, Eich G, Steinmann B, Boltshauser E, Giedion A. Schwartz-Jampel syndrome type 2 and Stüve-Wiedemann syndrome: a case for "lumping". AMERICAN JOURNAL OF MEDICAL GENETICS 1998; 78:150-4. [PMID: 9674906 DOI: 10.1002/(sici)1096-8628(19980630)78:2<150::aid-ajmg10>3.0.co;2-m] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Recent studies demonstrated the existence of a genetically distinct, usually lethal form of the Schwartz-Jampel syndrome (SJS) of myotonia and skeletal dysplasia, which we called SJS type 2. This disorder is reminiscent of another rare condition, the Stüve-Wiedemann syndrome (SWS), which comprises campomelia at birth with skeletal dysplasia, contractures, and early death. To test for possible nosologic identity between these disorders, we reviewed the literature and obtained a follow-up of the only two surviving patients, one with SJS type 2 at age 10 years and another with SWS at age 7 years. Patients reported as having either neonatal SJS or SWS presented a combination of a severe, prenatal-onset neuromuscular disorder (with congenital joint contractures, respiratory and feeding difficulties, tendency to hyperthermia, and frequent death in infancy) with a distinct campomelic-metaphyseal skeletal dysplasia. The similarity of the clinical and radiographic findings is so extensive that these disorders appear to be a single entity. The follow-up observation of an identical and unique pattern of progressive bone dysplasia in the two patients (one with SJS type 2, one with SWS) surviving beyond infancy adds to the evidence in favor of identity. The hypothesis that SWS and SJS type 2 are the same disorder should be testable by molecular methods.
Collapse
Affiliation(s)
- A Superti-Furga
- Division of Metabolic and Molecular Diseases, University Children's Hospital, Zurich, Switzerland.
| | | | | | | | | | | | | |
Collapse
|
25
|
Cormier-Daire V, Superti-Furga A, Munnich A, Lyonnet S, Rustin P, Delezoide A, De Lonlay P, Giedion A, Maroteaux P, Le Merrer M. Clinical homogeneity of the St�ve-Wiedemann syndrome and overlap with the Schwartz-Jampel syndrome type 2. ACTA ACUST UNITED AC 1998. [DOI: 10.1002/(sici)1096-8628(19980630)78:2<146::aid-ajmg9>3.0.co;2-m] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
26
|
Chabrol B, Sigaudy S, Paquis V, Montfort MF, Giudicelli H, Pellissier JF, Millet V, Mancini J, Philip N. Stüve-Wiedemann syndrome and defects of the mitochondrial respiratory chain. AMERICAN JOURNAL OF MEDICAL GENETICS 1997; 72:222-6. [PMID: 9382147 DOI: 10.1002/(sici)1096-8628(19971017)72:2<222::aid-ajmg18>3.0.co;2-p] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The Stüve-Wiedemann syndrome (SWS) comprises short stature, congenital bowing of the long bones, respiratory distress, and recurrent episodes of unexplained hyperthermia. The skeletal radiographic changes include short and broad long bones, large metaphyses, internal cortical thickening, and angulation primarily of tibiae and femora, but also of humeri and forearm bones. We report 3 cases of SWS from 2 different unrelated consanguineous gypsy families. All 3 cases fulfilled the clinical and radiological criteria of SWS. Two patients died shortly after birth, whereas the third one was alive at the age of one year. Besides hyperthermic episodes, one patient had hyperaminoaciduria, hepatic failure, and megaloblastic anemia which prompted us to investigate mitochondrial respiratory chain in 2 cases. Abnormal results consisting of decreased activities of complex I and IV were found in both. The simultaneous occurrence of both SWS phenotype and abnormal mitochondrial metabolism in two unrelated cases strongly supports the hypothesis of a pathogenetic relationship between the two events. These cases may also be related to recent reports on the effects of the mitochondrial respiratory chain defects on embryogenesis.
Collapse
Affiliation(s)
- B Chabrol
- Department of Neuropediatrics, Timone Hospital, Marseille, France
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
Stüve-Wiedemann syndrome (SWS) is, at last, beginning to emerge from the shadows of campomelic syndrome as a nosologically and, presumably, causally-distinct entity, first delineated in 1971 on the basis of 2 affected sisters. The fact that these sisters had an affected double first cousin supports autosomal-recessive inheritance of SWS.
Collapse
Affiliation(s)
- H R Wiedemann
- Department of Pediatrics, Christian-Albrechts Universität, Kiel, Germany
| | | |
Collapse
|